260 related articles for article (PubMed ID: 6309467)
1. Ranitidine: a new H2-receptor antagonist.
Berner BD; Conner CS; Sawyer DR; Siepler JK
Clin Pharm; 1982; 1(6):499-509. PubMed ID: 6309467
[TBL] [Abstract][Full Text] [Related]
2. Pharmacology and clinical efficacy of ranitidine, a new H2-receptor antagonist.
Helman CA; Tim LO
Pharmacotherapy; 1983; 3(4):185-92. PubMed ID: 6136952
[TBL] [Abstract][Full Text] [Related]
3. Ranitidine: a review of its pharmacology and therapeutic use in peptic ulcer disease and other allied diseases.
Brogden RN; Carmine AA; Heel RC; Speight TM; Avery GS
Drugs; 1982 Oct; 24(4):267-303. PubMed ID: 6128216
[TBL] [Abstract][Full Text] [Related]
4. Comparison of the effectiveness of ranitidine and cimetidine in inhibiting acid secretion in patients with gastric hypersecretory states.
Jensen RT; Collen MJ; McArthur KE; Howard JM; Maton PN; Cherner JA; Gardner JD
Am J Med; 1984 Nov; 77(5B):90-105. PubMed ID: 6150641
[TBL] [Abstract][Full Text] [Related]
5. Cimetidine-resistant Zollinger-Ellison syndrome: successful management with ranitidine.
Habal FM; Soldin SJ; Greenberg GR
Can Med Assoc J; 1983 Aug; 129(3):256-8. PubMed ID: 6305470
[TBL] [Abstract][Full Text] [Related]
6. Comparison of famotidine with cimetidine and ranitidine.
Berardi RR; Tankanow RM; Nostrant TT
Clin Pharm; 1988 Apr; 7(4):271-84. PubMed ID: 2896559
[TBL] [Abstract][Full Text] [Related]
7. Ranitidine--pharmacology and clinical use.
Dawson J; Richards DA; Stables R; Dixon GT; Cockel R
J Clin Hosp Pharm; 1983 Mar; 8(1):1-13. PubMed ID: 6132928
[No Abstract] [Full Text] [Related]
8. Ranitidine.
Strum WB
JAMA; 1983 Oct; 250(14):1894-6. PubMed ID: 6312110
[TBL] [Abstract][Full Text] [Related]
9. Kinetics and duration of action of ranitidine on gastric secretion and its effect on pancreatic secretion in duodenal ulcer patients.
Konturek SJ; Obtułowicz W; Kwiecień N; Kopp B; Oleksy J
Scand J Gastroenterol Suppl; 1981 Jun; 69():91-9. PubMed ID: 6119789
[TBL] [Abstract][Full Text] [Related]
10. Famotidine. The ACG Committee on FDA-Related Matters with primary authorship by G. Friedman. American College of Gastroenterology.
Am J Gastroenterol; 1987 Jun; 82(6):504-6. PubMed ID: 2883885
[TBL] [Abstract][Full Text] [Related]
11. H2-receptor antagonists in perspective.
Malagelada JR; Cortot A
Mayo Clin Proc; 1978 Mar; 53(3):184-90. PubMed ID: 24155
[TBL] [Abstract][Full Text] [Related]
12. A double-blind comparison of cimetidine and ranitidine as prophylaxis against gastric aspiration syndrome.
Morison DH; Dunn GL; Fargas-Babjak AM; Moudgil GC; Smedstad K; Woo J
Anesth Analg; 1982 Dec; 61(12):988-92. PubMed ID: 6128946
[TBL] [Abstract][Full Text] [Related]
13. [Ranitidine, a newly developed histamine H2-receptor antagonist. First experimental and clinical results].
Simon B; Dammann HG; Müller P; Kather H
Dtsch Med Wochenschr; 1980 Dec; 105(50):1753-5. PubMed ID: 6108203
[No Abstract] [Full Text] [Related]
14. Duodenal and gastric ulcer healing rates: a review.
Legerton CW
Am J Med; 1984 Nov; 77(5B):2-7. PubMed ID: 6095656
[TBL] [Abstract][Full Text] [Related]
15. Clinical and endocrine aspects of treatment with ranitidine.
Boyd EJ; Peden NR; Browning MC; Saunders JH; Wormsley KG
Scand J Gastroenterol Suppl; 1981 Jun; 69():81-3. PubMed ID: 6119787
[TBL] [Abstract][Full Text] [Related]
16. Review of peptic ulcer maintenance trials.
Robinson M
Am J Med; 1984 Nov; 77(5B):23-9. PubMed ID: 6095657
[TBL] [Abstract][Full Text] [Related]
17. [Side effects and safety of the new histamine H2 receptor antagonist ranitidine in the long-term treatment of patients with stomach and duodenal ulcers].
Meryn S; Pötzi R; Brunner H; Pesendorfer FX; Pamperl H
Wien Klin Wochenschr; 1983 Apr; 95(9):310-2. PubMed ID: 6137111
[TBL] [Abstract][Full Text] [Related]
18. A review of the animal pharmacology of ranitidine--a new, selective histamine H2-antagonist.
Brittain RT; Daly MJ
Scand J Gastroenterol Suppl; 1981 Jun; 69():1-9. PubMed ID: 6119770
[TBL] [Abstract][Full Text] [Related]
19. Furan H2-antagonist ranitidine inhibits pentagastrin-stimulated gastric secretion stronger than cimetidine.
Domschke W; Lux G; Domschke S
Gastroenterology; 1980 Dec; 79(6):1267-71. PubMed ID: 6108279
[TBL] [Abstract][Full Text] [Related]
20. [Therapy and prevention of duodenal and gastric ulcer with histamine-H2-receptor antagonists].
Hentschel E
Wien Med Wochenschr; 1983; 133(4-5):104-7. PubMed ID: 6134397
[No Abstract] [Full Text] [Related]
[Next] [New Search]
